Sunday, January 11, 2026

 

Why the world's cobalt supply chain is more fragile than it looks




Chinese Society for Environmental Sciences

Systemic risk and shock propagation in the global cobalt supply chain. 

image: 

Systemic risk and shock propagation in the global cobalt supply chain. This schematic illustrates the multilayer structure of the global cobalt supply chain and how localized disruptions propagate through it. Trade flows connect countries within each life-cycle stage (mining, refining, manufacturing, use, waste management, and recycling), while interlayer links represent transformative flows between stages. Shocks originating at a specific country or stage can spread through both direct and indirect pathways, cascading horizontally across economies and vertically along the supply chain. Systemic risk is quantified using two indicators—systemic fragility and exposure rate—highlighting how concentrated production and strong interdependencies can amplify small disturbances into large-scale network failures.

view more 

Credit: Environmental Science and Ecotechnology




Cobalt is a cornerstone material for lithium-ion batteries and electric vehicles, yet its global supply chain is increasingly exposed to systemic risks that go far beyond isolated supply disruptions. This study reveals how shocks originating in one country or production stage can cascade across borders and life-cycle stages, triggering widespread failures throughout the global cobalt supply chain network. By integrating material flow analysis with a multilayer shock propagation model, the research demonstrates that systemic risks concentrate upstream but accumulate most severely at refining and manufacturing bottlenecks. Alternating horizontal/vertical and direct/indirect shock propagation pathways lengthen cascades, expose multistage knock-ons, and produce abrupt, nonlinear breakdowns, highlighting that conventional, country-level risk assessments underestimate the true vulnerability of the cobalt supply system and that system-level coordination is essential for resilience. 

As electric vehicles and energy storage systems expand worldwide, demand for cobalt has surged, intensifying concerns over supply security, geopolitical concentration, and environmental and social risks. Traditional assessments of critical minerals often evaluate countries, materials, or trade flows in isolation, overlooking the dense upstream–downstream interdependencies that characterize modern supply chains. Recent disruptions—from export restrictions and trade tensions to pandemic-related shocks—have shown that even localized disturbances can ripple through global production systems. However, existing analytical frameworks struggle to capture how risks propagate across multiple production stages and economies simultaneously. Based on these challenges, it is necessary to conduct in-depth research on cobalt supply chain risks from a systemic, network-based perspective.

In a study (DOI: 10.1016/j.ese.2025.100654) accepted in Environmental Science and Ecotechnology and published online in late 2025, researchers from institutions including the Chinese Academy of Sciences, Peking University, and the University of Southern Denmark analyzed global cobalt flows from 1998 to 2019. Using a multilayer supply chain network and an iterative shock propagation model, the team examined how disruptions spread horizontally across countries and vertically across six life-cycle stages, from mining and refining to manufacturing, use, and recycling. Their findings offer one of the most comprehensive assessments to date of systemic risk in the global cobalt supply chain.

The researchers constructed a global cobalt supply chain network linking 230 countries across six interconnected production stages, combining trade-linked material flow analysis with a dynamic shock-propagation model. This approach allowed them to simulate how supply shortages or demand reductions in one node could trigger cascading failures throughout the system. The results show that shocks propagate through alternating direct and indirect pathways, often traveling across both trade relationships and domestic production chains. While mining disruptions—particularly in highly concentrated upstream regions—are frequent risk sources, the most severe systemic impacts accumulate at refining and manufacturing "bridges", where dense vertical and horizontal connections amplify failures.

The analysis reveals that the resulting "avalanche network" of potential failures is roughly four times denser than the physical trade network itself, indicating extensive hidden interdependencies. Countries such as China and the United States exhibit high systemic fragility, meaning disruptions originating there can trigger widespread collapses. Conversely, several countries with relatively small production volumes but high exposure rates are particularly vulnerable to common random disruptions and lack resilience or effective response. Overall, the study finds that global cobalt supply risks have followed a volatile yet rising trend over the past two decades, driven by increasing concentration and misalignment between supply and demand.

The authors emphasize that the cobalt supply chain displays a "robust-yet-fragile" structure: it can absorb random, small-scale disruptions, yet remains highly vulnerable to targeted shocks at critical nodes. They note that interventions such as national stockpiling or reshoring may reduce risks for individual countries but can unintentionally shift vulnerabilities elsewhere in the system. According to the research team, improving resilience requires coordinated, stage-aware strategies that recognize upstream–downstream coupling rather than isolated national responses. Without such system-level thinking, efforts to secure critical minerals for the energy transition may exacerbate, rather than alleviate, global supply instability.

The findings carry important implications for energy policy, critical mineral governance, and industrial strategy. By revealing where risks originate, accumulate, and propagate, the framework can support early-warning systems for supply disruptions and guide more effective international cooperation. Policymakers can use these insights to design joint stockpiling mechanisms, diversify refining and manufacturing capacity, and evaluate the systemic consequences of trade restrictions or decoupling strategies. Beyond cobalt, the approach can be applied to other critical materials essential for batteries and clean energy technologies. Ultimately, the study suggests that ensuring a stable low-carbon transition depends not only on securing resources, but on managing the complex networks that connect them.

###

References

DOI

10.1016/j.ese.2025.100654

Original Source URL

https://doi.org/10.1016/j.ese.2025.100654

Funding information

This work was financially supported by the National Natural Science Foundation of China (72334001, 42530502, and 52270191) and the Humanities and Social Sciences Fund of the Ministry of Education of China (23JZD018).

About Environmental Science and Ecotechnology

Environmental Science and Ecotechnology (ISSN 2666-4984) is an international, peer-reviewed, and open-access journal published by Elsevier. The journal publishes significant views and research across the full spectrum of ecology and environmental sciences, such as climate change, sustainability, biodiversity conservation, environment & health, green catalysis/processing for pollution control, and AI-driven environmental engineering. The latest impact factor of ESE is 14.3, according to the Journal Citation ReportsTM 2024.

 

Breastfeeding may lower mothers’ later life depression and anxiety risks


The observed associations were evident for any, exclusive, and cumulative (at least 12 months) breastfeeding, the study shows.




UCD Research & Innovation

Breastfeeding may lower mothers’ later life depression and anxiety risks 

image: 

Corresponding author, Professor Fionnuala McAuliffe, Chair and Full Academic Professor of Obstetrics and Gynaecology, UCD School of Medicine and Director UCD Perinatal Research Centre.

view more 

Credit: University College Dublin





Breastfeeding may lower mothers’ later life risks of depression and anxiety for up to 10 years after pregnancy, suggest the findings of an observational study, published in the open access journal BMJ Open.

The observed associations were evident for any, exclusive, and cumulative (at least 12 months) breastfeeding, the study shows.

It is known that breastfeeding reduces the risk of postnatal depression and anxiety, but it’s not clear if these lowered risks might persist in the longer term, say the researchers. To find out, they tracked the breastfeeding behaviour and health of 168 second time mothers who were originally part of the ROLO Longitudinal Birth Cohort Study for 10 years after pregnancy.

Corresponding author, Professor Fionnuala McAuliffe (Chair and Full Academic Professor of Obstetrics and Gynaecology, UCD School of Medicine and Director UCD Perinatal Research Centre), says: "The finding that breastfeeding may reduce mothers’ later life chance of depression and anxiety is very exciting and is another great reason to support our mothers to breastfeed."

The women were recruited from early pregnancy and they and their children had check-ups at 3 and 6 months, and 2, 5, and 10 years after birth, by which time their average age of mothers was 42 years.

At each check-up, the mothers completed a detailed health history questionnaire. This asked whether they had been diagnosed with, and treated for, depression and or anxiety. They also provided information on potentially influential factors, including diet and physical activity levels.

At these follow ups, the mothers provided information on whether they had ever breastfed or expressed milk for 1 day or more; total number of weeks of exclusive breastfeeding; total number of weeks of any breastfeeding; and cumulative periods of breastfeeding of less or more than 12 months. 

Nearly three quarters of the women (73%; 122) reported having breastfed at some point. The average period of exclusive breastfeeding lasted 5.5 weeks and that of any breastfeeding for 30.5 weeks. More than a third (37.5%; 63) reported cumulative lifetime periods of breastfeeding adding up to at least 12 months.

Some 22 (13%) of the women reported depression/anxiety at the 10-year check-up, with a further 35 (21%) reporting depression or anxiety at any time point.

Those reporting depression/anxiety at the 10-year check-up were younger, less physically active and had lower wellbeing scores at the start of the study than those who didn’t report this.

Analysis of the data showed that women experiencing depression and anxiety at 10 years after pregnancy were less likely to have breastfed and had shorter durations of any or exclusive breastfeeding over their lifetime.

Each week of lifetime exclusive breastfeeding was associated with a 2% lower likelihood of reporting depression and anxiety, after accounting for potentially influential factors, including alcohol intake.

This is an observational study, and as such, no firm conclusions can be drawn about cause and effect, associations only can be relied upon.

Nevertheless, the team wrote: “We suggest there also may be a protective effect of successful breastfeeding on postpartum depression and anxiety, which in turn lowers the risk of maternal depression and anxiety in the longer term.”  

They said: “The likelihood is that the association is multifactorial, as many socioeconomic and cultural factors influence both breastfeeding and mental health. Additionally, women with a prior history of depression and anxiety are at risk of lower breastfeeding success, compounding the association.”

They said: “We know that improving breastfeeding rates and duration can improve mothers’ lifetime health outcomes in terms of less diabetes and heart disease and reduces at population level disease burden with resultant significant healthcare savings.

“The possibility that breastfeeding could further reduce the huge burden of depression on individuals, families, healthcare systems and economies only adds to the argument for policymakers to further promote breastfeeding.”

 

Understanding the health issues set to dominate 2026

Experts identify the main health challenges for 2026.
Copyright STR/Copyright 2020 The AP. All rights reserved.


By Marta Iraola Iribarren
Published on 

Shifting global health leadership, AI, and climate change are set to shape the health agenda this year, amid funding cuts and workforce shortages.

What are the main challenges in global health this year? We reached out to experts to highlight the priorities that are likely to dominate the agenda, and the topics expected to take centre stage in 2026.

From shifts in global health leadership to climate change and artificial intelligence (AI) in healthcare, these issues will shape policy, drive debate, and determine who leads the global conversation.

Who takes the lead in global health?

Global health faced a major shock last year when Donald Trump’s administration in the United States announced unprecedented cuts to humanitarian and development aid.

Since then, several countries have followed suit, shifting their priorities and limiting resources for international health programmes.

“Recent funding pauses for global health initiatives are creating headwinds for progress, with effects that could persist into 2026 if uncertainty continues,” warned Anja Langenbucher, Europe office director at the Gates Foundation. “This comes at a moment when child mortality is edging back up for the first time this century.

She noted that there are still reasons for “cautious optimism”, pointing to AI-enabled tools that can improve health service targeting, next generation vaccines, and climate-smart agriculture that enhances resilience and productivity.

“With stable platforms and more stable funding in place – areas where the EU and others are already well placed to lead – 2026 could be a year when distant possibilities in health become realistic solutions,” Langenbucher told Euronews Health.

The Global Fund to Fight AIDS, Tuberculosis and Malaria highlighted malaria as a key challenge for the months ahead.

The organisation said stalled progress on stemming malaria and growing drug resistance exemplify the consequences of underfunded and poorly integrated prevention, primary care, and community delivery systems.

“Taken together, the year ahead will be defined by hard choices, but also by an opportunity to refocus global health around impact, integration, and country leadership – with the ultimate measure being whether we can protect the most vulnerable from entirely preventable diseases,” a spokesperson from the Global Fund said.

Growing opportunities for technological innovation

AI and other new technologies are expected to transform healthcare this year, driving advances in diagnostics, drug development, and workload reduction for healthcare professionals.

Philips, a global health technology company, pointed to AI’s potential for reducing healthcare workers’ daily workload as one of the most promising advances.

“Healthcare is entering a new phase, with AI creating new possibilities for how care is delivered and experienced, and helping make sense of an increasingly complex system,” a Philips spokesperson told Euronews Health.

By easing administrative pressure, clinicians can focus more of their time and attention on patient care, while AI works in the background to improve efficiency, the spokesperson added

Across Europe, biotechnology is also advancing rapidly, with the recently presented EU Biotech Act set to take the centre stage in policy discussions.

“If we had to sum up, what we expect in 2026 is the year of biotechnology for Europe to contribute to strategic autonomy, to the competitiveness of the continent,” a spokesperson from Spanish biotech pharmaceutical HIPRA told Euronews health.

HIPRA also highlighted biotech’s growing role in security and biodefence – both to counter biological threats and to enable a rapid response to health emergencies such as future pandemics through advanced diagnostics, vaccines, and other medical countermeasures.

“All these infrastructures, all these investments prepare us for any kind of threat, be it natural or a pathogen that jumps from human animals or created in laboratories,” HIPRA’s spokesperson added, saying this preparedness will be key to Europe’s competitiveness.

Healthcare systems and workforces under pressure

Another major challenge healthcare systems are facing is a growing workforce shortage amid rising demand, ageing populations, and worsening mental health among professionals.

“We can expect workforce constraints will remain central to health policy debates in 2026,” said Katherine de Bienassis, health policy analyst at Organisation for Economic Co-operation and Development (OECD).

She told Euronews Health that persistent shortages of nurses, primary care physicians, and specialists are common across OECD countries, reducing system capacity and exacerbating inequities.

“Methods for ensuring health system productivity are likely to become increasingly central as systems strive to deliver more with fewer resources, while also maintaining patient outcomes,” de Bienassis added.

Climate change and emerging threats

As the effects of climate change intensify, new health challenges emerge – from faster spread of mosquito-borne diseases to impacts of biodiversity loss and rising pollution levels.

“Science shows no sign that this [climate] crisis is slowing, while EU policy attention remains focused elsewhere,” Génon K. Jensen, director at the Health and Environment Alliance, told Euronews Health.

She said policymakers should seize the opportunity to reduce costs, boost productivity, and prevent disease by prioritising environmental and climate policies – including the revision of the EU’s chemicals regulation.

“People’s health should be central to this year’s climate resilience proposals, with nature-based solutions as a cornerstone of climate adaptation,” Jensen said.

Competitiveness tug of war

The pharmaceutical sector has been navigating an unstable trade environment in recent months, marked by tariffs and geopolitical tensions that will continue to shape markets in 2026.

“Europeans have been turning a blind eye to the fact that Americans pay two to three times more for patented drugs than they do,” said Elizabeth Kuiper, associate director of the European Policy Centre.

She added that Trump's threat of tariffs on pharmaceuticals served as a wake-up call to approach the sector more strategically, as one of the key drivers of innovation and economic growth for the EU.

An opportunity for new focuses

2026 could also be a year for new health topics to move up the agenda.

“We also really hope to see the growing awareness of the gender health gap that we saw in 2025 result in dedicated funding, and strong political commitment, like an EU Women's Health Strategy,” said Ffion Storer-Jones, senior policy and advocacy officer at DSW, an international non-profit working in sexual and reproductive health.

She also warned that growing rates of sexually transmitted infections and antimicrobial resistance will remain a cross-border public health threat that must not be overlooked.

“We really hope that 2026 does not become another year of neglect in the global health 'panic and neglect' cycle,” Storer-Jones said.

 

Johns Hopkins Children’s Center study tracks declines in annual checkups as teens become young adults




Johns Hopkins Medicine






It’s common that as kids get to high school and transition to adulthood, they begin to skip yearly wellness visits with a pediatrician or other primary care provider. And, as expected, skipping those checkups can have serious health consequences, including missed early markers of diseases and disorders that come with growing older and are treatable with early interventions. 

A new study led by Johns Hopkins Children’s Center researchers using data on adolescents and young adults (AYAs) ages 15 to 23 has added to evidence that as kids get to high school and transition to adulthood, many begin to skip yearly wellness visits with a pediatrician or other primary care provider. 

The findings, they say, should advance efforts by parents, pediatricians and other primary care providers to encourage annual wellness visits, as recommended by the American Academy of PediatricsFindings from this study, funded by the Health Resources and Services Administration Maternal and Child Health Bureau, were published Dec. 19 in the Journal of Adolescent Health.

Children’s Center researchers say AYAs face a critical period of vulnerability during the transition to adulthood, when serious relationships begin, new jobs start and environments shift. 

“These life changes can have physical and mental health impacts. Attending yearly wellness visits is an opportunity to screen and provide care for risky or dangerous behavior, including drug use,” says Johns Hopkins Children’s Center pediatrician and adolescent medicine specialist Arik V. Marcell, M.D., M.P.H. 

The new study, led by Marcell and Children’s Center fellow Morayo Akande, Ph.D., M.P.H., analyzed data for both male and female AYAs gathered from the NEXT Generation Health Study funded in part by the Eunice Kennedy Shriver National Institute of Child Health and Human Development. That study was designed to study health outcomes by following the same AYAs for seven years, starting from ages ranging from 15 to 23. As part of the current study, Johns Hopkins researchers tracked how often the AYAs got yearly checkups and what factors contributed to them continuing or not continuing to go. 

For the new study, the researchers grouped males as either engaged, engaged with decline or persistently disengaged from going to checkups during the seven-year period. Females were grouped as either engaged, engaged with decline or gradually reengaged. 

Results showed that a majority of both sexes were found to be engaged, meaning they received a yearly wellness visit. However, more than 30% of males and nearly 20% of females became disengaged as they got older. Marcell says this is very concerning since these young people will have fewer opportunities to get preventive care, especially during a period when engaging in riskier behaviors begins or escalates, including behaviors related to drug use and sexual activity. 

Researchers identified a couple possible reasons for the decline in primary care visits. For example, when children go away to college, parents no longer make their appointments for them. Additionally, adolescents are more inclined to see only specialized physicians for specific complaints — such as when a girl begins seeing a gynecologist. These specialists may be mistakenly perceived by AYAs as a replacement for primary care. 

The study also found that about 13% of girls and young women “gradually reengaged,” meaning that during the seven years of tracking, they tended to go back to a primary care doctor. Marcell says that girls and young women have more health-related concerns and “touchpoints” that may lead them to make a wellness appointment — including changes in menstrual cycles, the need for birth control, or concerns about pregnancy — than do boys and young men. 

Additionally, the study found that boys and young men with chronic health problems were more likely to stay engaged with their wellness visits. However, females with mental health symptoms were less likely to be engaged. 

The current study adds to evidence found in a previous study led by Marcell and colleagues, which showed that from middle childhood (age 5) to late adolescence (age 17), about half of children had wellness visits. However, half of boys’ wellness visits dropped off after they turned 5 — when vaccines are required for school entry — and at far higher rates than girls’ wellness visit patterns. Also, among boys whose wellness visits dropped off, one-third continued to be disconnected from preventive care through age 17, versus less than 10% of girls over the same timeframe. 

Marcell recommends that all parents and AYAs need to understand the value of the annual preventive care wellness visit, and that parents teach their children how to make a primary care checkup appointment. He says attention to health care is a learned behavior, and it’s never too early to begin those conversations and to practice those skills. 

Based on the findings in the study, Marcell also believes more research and longitudinal data, such as those collected in the NEXT data set, can help primary care providers better understand who is and isn’t being seen, and focus some attention on reaching out to AYAs. 

Other authors in this study include Kathryn Van Eck, Xingyun Wu, Elianna Perrin, Lingxin Hao and Pamela Matson with Johns Hopkins and Elizabeth Ozer with the University of California, San Francisco. 

The study was funded by the U.S. Health Resources & Services Administration Maternal and Child Health Bureau (R42MC49146 and U8DMC45901). The original NEXT study was funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (HHSN275201200001I), the National Heart, Lung, and Blood Institute, the National Institute on Alcohol Abuse and Alcoholism and the National Institute on Drug Abuse. 

No authors declared conflicts of interest under Johns Hopkins University School of Medicine policies.

For more information about Johns Hopkins Children’s Center research and how it saves lives, visit the Johns Hopkins Medicine Research Saves Children website.